logo
  

Gilead Sciences: FDA Approves Low-dose Tablet Dosage Form Of Biktarvy For Pediatric patients

Gilead Sciences, Inc. (GILD) announced the FDA approved a new low-dose tablet dosage form of Biktarvy for pediatric patients weighing at least 14 kg to less than 25 kg who are virologically suppressed or new to antiretroviral therapy. The company said this approval expands the indication for Biktarvy to include younger children living with HIV-1 infection.

Merdad Parsey, Chief Medical Officer, Gilead Sciences, said: "The sNDA approval is an important step in fulfilling Gilead's commitment to a goal of bringing pediatric formulations of Biktarvy to children living with HIV around the world."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Buena, New Jersey-based Teligent Pharma, Inc. is recalling two lots of Lidocaine HCl Topical Solution USP 4%, 50ml to the user level due to super potency, the U.S. Food and Drug Administration said. The product is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract. Meta Platforms Inc., the parent of Facebook, Instagram, and WhatsApp, said it is launching more options on WhatsApp to control their messages and how long they stick around, with default disappearing messages and multiple durations. The latest features are expected to bring more control and privacy on the popular messaging app. Delivery services company DoorDash has introduced ultra-fast grocery deliveries with DashMart in Chelsea, New York City. The company said it aims to deliver in 10-15 minutes and plans to expand its new service in select DoorDash grocery and convenience partners over the next year. With over 2,000 items, DashMart offers a wide assortment of fresh and frozen grocery staples, snacks, household goods, and local products.
Follow RTT